Freeline Therapeutics Holdings plc - ADR

NASDAQ:FRLN   3:52:12 PM EDT
0.69
-0.01 (-1.50%)
Earnings Announcements

Freeline Reports First Quarter 2022 Results And Business Highlights

Published: 05/10/2022 21:05 GMT
Freeline Therapeutics Holdings plc - ADR (FRLN) - Freeline Reports First Quarter 2022 Financial Results and Business Highlights.
Qtrly Loss per Share $0.63.
Q1 Earnings per Share View $-0.61 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.50

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.48

More details on our Analysts Page.